We have demonstrated, to the best of our knowledge for the first time, the effects of short (1-day) and prolonged (2-weeks, 10-weeks) in vivo administrations of testosterone enanthate (TE) on molecular markers of pituitary functionality as well as prolactin (PRL) and cAMP signaling in Leydig cells.
|Cell lines||Leydig cells|
|Preparation method||For in vitro experiments the primary cultures of purified Leydig cells were isolated from undisturbed rats and plated for monitoring genes expression. After 2 h of recovery, the culture medium was trashed and the Leydig cells were incubated for 20 h without (CUT, untreated (control) cells) or with test osterone (T, 20 μM ) or cyproterone-acetate (CPA, 100 μM ) or combination CPA (100 μM ) + T (20 μM ), or in presence of hCG (5 192 and 50 ng/ml) as a positive control.|
|Incubation time||20 h|
|Animal models||male Wistar rats|
|Dosages||0.5mg/100g or 2.5 mg/100g|
|Body Surface Area (m2)||0.007||0.025||0.15||0.05||0.02||0.5|
|Animal A (mg/kg) = Animal B (mg/kg) multiplied by||Animal B Km|
|Animal A Km|
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
|Solubility||10 mM in DMSO|
Prolonged in vivo administration of testosterone-enanthate, the widely used and abused anabolic androgenic steroid, disturbs prolactin and cAMP signaling in Leydig cells of adult rats.
Bjelic MM, et al. J Steroid Biochem Mol Biol. 2015 May;149:58-69. PMID: 25603467.
Molecular adaptations of testosterone-producing Leydig cells during systemic in vivo blockade of the androgen receptor.
Bjelic MM, et al. Mol Cell Endocrinol. 2014 Oct;396(1-2):10-25. PMID: 25153259.
|Related Androgen Receptor Products|
Dehydroepiandrosterone is an effective antiapoptotic factor.
ASC-J9, also known as GO-Y025 and Dimethylcurcumin, suppressesing castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors.
GSK 2881078 is a selective androgen receptor modulator potentially for the treatment of cachexia. GSK 2881078 is a selective androgen receptor modulator (SARM) that is being evaluated for effects on muscle growth and strength in subjects with muscle wasting to improve their physical function.
Indacaterol(Onbrez; Arcapta) is an ultra-long-acting β-adrenoceptor agonist.
Nandrolone phenylpropionate (NPP) is an anabolic-androgenic steroid. The low androgenicity and enhanced anabolic activity of NPP has shown to positively influence calcium metabolism and to increase bone mass in osteoporosis.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.